Visteon Sponsors University of Michigan Health System Research Program

    DEARBORN, Mich., Feb. 6 Visteon Corporation
announced today that it is the first company in the automotive industry to
help fund the University of Michigan Health System's medical research program,
UMPIRE (University of Michigan Program for Injury Research and Education).
Visteon chose to support this organization because UMPIRE shares Visteon's
philosophy of developing automotive products and technologies that are
designed to improve the safety and security of consumers.
    (Photo:  http://www.newscom.com/cgi-bin/prnh/20001201/DEF008LOGO )
    "This unique program will take the industry in an all-new direction for
accident research, data analysis, design and performance validation," said
John Barkley, Director of Cross-Systems Development for Visteon Corporation.
    Under the direction of Dr. Stewart Wang, UMPIRE is a unique program that
will enable the automotive industry to learn from the medical community, which
will result in a better understanding of the effects of occupant impact in
vehicle crashes.  Visteon plans to use data from the program to design and
develop enhanced future automotive products and technologies.  Conversely, the
medical community will gain greater insight that will aid in improved trauma
patient care.
    As one of the world's largest suppliers of integrated automotive
components and systems, Visteon's product and technology roadmap begins with
safety.  The company has designed and developed several products and systems
that will help keep drivers safe and secure as they travel from destination-
to-destination.  These products and technologies include:  Visteon Voice
Technology(TM), which helps reduce driver distraction; NavMate(R) Navigation
System, which helps drivers arrive at their destination safely and easily;
radar detection systems that provide warning of nearby objects; and collision
avoidance systems, to name a few.  The next phase for improving these and many
other Visteon products and technologies will include the valuable medical
insight provided by data analysis from the UMPIRE program.
    Visteon Corporation is a leading full-service supplier that delivers
consumer-driven technology solutions to automotive manufacturers worldwide and
through multiple channels within the global automotive aftermarket.  Visteon
has 80,000 employees and a global delivery system of more than 130 technical,
manufacturing, sales, and service facilities located in 23 countries.
    This press release contains forward-looking statements made pursuant to
the Private Securities Litigation Reform Act of 1995.  Words such as
"estimated" and "potentially" signify forward-looking statements.  Forward-
looking statements are not guarantees of future results and conditions but
rather are subject to various risks and uncertainties, some of which are and
will be identified as "Risk Factors" in Visteon's SEC filings.  See "Risk
Factors" section of Visteon's prospectus dated June 13, 2000 as filed with the
SEC on June 14, 2000.  Should any risks and uncertainties develop into actual
events, these developments could have material adverse effects on Visteon's
business, financial condition and results of operations.